Abstract:Objective To investigate the correlation of serum high mobility group box-1 (HMGB1) level and acute myocardial infarction (AMI).Methods The 348 patients with acute ST-elevation myocardial infarction (STEMI) who underwent percutaneous coronary intervention in our hospital from January 2016 to November 2018 were selected, and another 312 healthy subjects taking physical examination were enrolled as the control group. The onset-to-balloon (OTB) time was recorded, and serum levels of HMGB1, total cholesterol, triglyceride, low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), cardiac troponin I and brain natriuretic peptide (BNP) were measured. Left ventricular end-diastolic dimension (LVEDD) and left ventricular ejection fraction (LVEF) were detected by two-dimensional echocardiography.Results The HDL and LVEF were lower, but LDL, BNP, LVEDD and HMGB1 were higher in AMI group compared with control group (P < 0.05). Serum level of HMGB1 positively correlated with OTB time, LDL, BNP, LVEDD, and cardiac troponin I (r = 0.896, 0.667, 0.647, 0.623 and 0.781, respectively, all P < 0.05), but negatively correlated with HDL and LVEF (r = -0.774 and -0.739, respectively, both P < 0.05). The level of serum HMGB1 was significantly higher in AMI group than that in the control group (P < 0.05). The area under the receiver operating characteristic curve of HMGB1 for predicting the occurrence of atrial fibrillation after AMI was 0.76 (95% CI: 0.69, 0.82), and the optimal cutoff value was 7.28 μg/L, with a sensitivity of 72.0% (95% CI: 67.28%, 76.72%) and a specificity of 62.4% (95% CI: 57.31%, 67.49%).Conclusions Serum HMGB1 level is significantly correlated with AMI, and has a predictive value for the occurrence of atrial fibrillation after AMI. Monitoring the level of serum HMGB1 has certain clinical significance for the diagnosis and treatment of AMI.